PropertyValue
?:definition
  • Molecular assay reagents intended to identify genetic variants associated with altered patient response to psychiatric pharmaceuticals (e.g., antidepressants, antipsychotics). Genetic variants at multiple loci have been associated with altered pharmacokinetics or pharmacodynamics of psychiatric pharmaceuticals. These reagents are intended to detect various types of genetic changes (e.g., deletions, duplications, insertions, substitutions) in multiple psychiatric pharmacogenetic loci simultaneously.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C4287268_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C4287268_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all